Intra-Cellular Therapies Inc. short interest in 2022
In 2022, Intra-Cellular Therapies Inc.'s disclosed short interest ran from 5.50% of shares outstanding on 14 Jan 2022 to 3.39% on 30 Dec 2022, a change of -2.11 percentage points. The year's high was 5.91% on 15 Feb 2022 and its low 2.95% on 30 Nov 2022, averaging 4.11% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.03 days on 30 Dec 2022. Full history: Intra-Cellular Therapies Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025
2022 in figures
- Start of year
- 5.50% (14 Jan 2022)
- End of year
- 3.39% (30 Dec 2022)
- Change
- -2.11 pp
- High
- 5.91% (15 Feb 2022)
- Low
- 2.95% (30 Nov 2022)
- Average
- 4.11%
- Highest days to cover
- 7.03 (30 Dec 2022)
- SEC filings marked
- 9
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 5.50% | 2.00 | results (8-K) |
| 31 Jan 2022 | 5.81% | 3.98 | |
| 15 Feb 2022 | 5.91% | 5.07 | |
| 28 Feb 2022 | 5.21% | 4.48 | |
| 15 Mar 2022 | 4.60% | 4.83 | 10-K filed, results (8-K) |
| 31 Mar 2022 | 4.11% | 4.26 | |
| 14 Apr 2022 | 4.06% | 4.25 | |
| 29 Apr 2022 | 3.57% | 4.00 | |
| 13 May 2022 | 4.11% | 3.14 | 10-Q filed, results (8-K) |
| 31 May 2022 | 3.33% | 4.06 | |
| 15 Jun 2022 | 3.84% | 6.00 | |
| 30 Jun 2022 | 3.90% | 3.98 | |
| 15 Jul 2022 | 3.96% | 6.13 | |
| 29 Jul 2022 | 3.57% | 6.47 | |
| 15 Aug 2022 | 3.96% | 3.66 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 3.49% | 4.33 | |
| 15 Sep 2022 | 4.02% | 6.56 | |
| 30 Sep 2022 | 4.32% | 4.90 | |
| 14 Oct 2022 | 4.26% | 6.53 | |
| 31 Oct 2022 | 4.30% | 6.24 | |
| 15 Nov 2022 | 3.35% | 3.52 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 2.95% | 5.52 | |
| 15 Dec 2022 | 3.16% | 5.45 | |
| 30 Dec 2022 | 3.39% | 7.03 |
See also: Intra-Cellular Therapies Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.